These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22267869)

  • 21. Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity.
    Mishra J; Mori K; Ma Q; Kelly C; Barasch J; Devarajan P
    Am J Nephrol; 2004; 24(3):307-15. PubMed ID: 15148457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between in vitro phospholipidosis assay using HepG2 cells and 2-week toxicity studies in rats.
    Miyamoto S; Matsumoto A; Mori I; Horinouchi A
    Toxicol Mech Methods; 2009 Oct; 19(8):477-85. PubMed ID: 19793005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of drugs inducing phospholipidosis by novel in vitro data.
    Muehlbacher M; Tripal P; Roas F; Kornhuber J
    ChemMedChem; 2012 Nov; 7(11):1925-34. PubMed ID: 22945602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phospholipidosis assay in HepG2 cells and rat or rhesus hepatocytes using phospholipid probe NBD-PE.
    Bhandari N; Figueroa DJ; Lawrence JW; Gerhold DL
    Assay Drug Dev Technol; 2008 Jun; 6(3):407-19. PubMed ID: 18537465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Multiplatform Approach for the Discovery of Novel Drug-Induced Kidney Injury Biomarkers.
    Chen L; Smith J; Mikl J; Fryer R; Pack F; Williams BJ; Phillips JA; Papov VV
    Chem Res Toxicol; 2017 Oct; 30(10):1823-1834. PubMed ID: 28885000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a novel set of biomarkers for evaluating phospholipidosis-inducing potential of compounds using rat liver microarray data measured 24-h after single dose administration.
    Yudate HT; Kai T; Aoki M; Minowa Y; Yamada T; Kimura T; Ono A; Yamada H; Ohno Y; Urushidani T
    Toxicology; 2012 May; 295(1-3):1-7. PubMed ID: 22426296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of novel renal biomarkers with a cisplatin model of kidney injury: gender and dosage differences.
    Pinches M; Betts C; Bickerton S; Burdett L; Thomas H; Derbyshire N; Jones HB; Moores M
    Toxicol Pathol; 2012 Apr; 40(3):522-33. PubMed ID: 22491933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of putative genomic biomarkers of nephrotoxicity in rats.
    Wang EJ; Snyder RD; Fielden MR; Smith RJ; Gu YZ
    Toxicology; 2008 Apr; 246(2-3):91-100. PubMed ID: 18289764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the relative performance of 12 urinary biomarkers for renal safety across 22 rat sensitivity and specificity studies.
    Vlasakova K; Erdos Z; Troth SP; McNulty K; Chapeau-Campredon V; Mokrzycki N; Muniappa N; Gu YZ; Holder D; Bailey WJ; Sistare FD; Glaab WE
    Toxicol Sci; 2014 Mar; 138(1):3-20. PubMed ID: 24361871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenylacetylglycine, a putative biomarker of phospholipidosis: its origins and relevance to phospholipid accumulation using amiodarone treated rats as a model.
    Delaney J; Neville WA; Swain A; Miles A; Leonard MS; Waterfield CJ
    Biomarkers; 2004; 9(3):271-90. PubMed ID: 15764292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute biomarker panel changes associated with amphotericin B nephrotoxicity in female Sprague-Dawley rats.
    McDuffie JE; Lee S; Ma JY; Chen Y; Snook S
    J Toxicol Sci; 2016; 41(4):459-68. PubMed ID: 27432232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of metabolic activation leading to drug-induced phospholipidosis in rat hepatocyte spheroids.
    Takagi M; Sanoh S; Santoh M; Ejiri Y; Kotake Y; Ohta S
    J Toxicol Sci; 2016 Feb; 41(1):155-64. PubMed ID: 26763403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological qualification of biomarkers of chemical-induced renal toxicity in two strains of male rat.
    Harpur E; Ennulat D; Hoffman D; Betton G; Gautier JC; Riefke B; Bounous D; Schuster K; Beushausen S; Guffroy M; Shaw M; Lock E; Pettit S;
    Toxicol Sci; 2011 Aug; 122(2):235-52. PubMed ID: 21593213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison between male and female Sprague-Dawley rats in the response of urinary biomarkers to injury induced by gentamicin.
    Gautier JC; Gury T; Guffroy M; Masson R; Khan-Malek R; Hoffman D; Pettit S; Harpur E
    Toxicol Pathol; 2014 Oct; 42(7):1105-16. PubMed ID: 24717899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of di-docosahexaenoyl (C22:6)-bis(monoacylglycerol) phosphate in unlabelled and C-13 labelled forms for use as a biomarker of drug induced phospholipidosis.
    Hickey MJ; Lindqvist J; Ha YH; Andersson H; Elmore CS
    J Labelled Comp Radiopharm; 2019 Sep; 62(11):695-706. PubMed ID: 30793359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-induced generalized phospholipidosis.
    Shikata T; Kanetaka T; Endo Y; Nagashima K
    Acta Pathol Jpn; 1972 Aug; 22(3):517-31. PubMed ID: 4678598
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug-induced phospholipidosis is caused by blockade of mannose 6-phosphate receptor-mediated targeting of lysosomal enzymes.
    Ikeda K; Hirayama M; Hirota Y; Asa E; Seki J; Tanaka Y
    Biochem Biophys Res Commun; 2008 Dec; 377(1):268-74. PubMed ID: 18840403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary metabolic fingerprinting for amiodarone-induced phospholipidosis in rats using FT-ICR MS.
    Hasegawa M; Takenaka S; Kuwamura M; Yamate J; Tsuyama S
    Exp Toxicol Pathol; 2007 Oct; 59(2):115-20. PubMed ID: 17719757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrasting effects of gentamicin and mercuric chloride on urinary excretion of enzymes and phospholipids in the rat.
    Josepovitz C; Levine R; Lane B; Kaloyanides GJ
    Lab Invest; 1985 Apr; 52(4):375-86. PubMed ID: 2858601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Immunohistochemical Investigation of Renal Phospholipidosis and Toxicity in Rats.
    Ma JY; Snook S; Garrovillo S; Johnson C; La D
    Int J Toxicol; 2017; 36(5):386-394. PubMed ID: 28820006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.